As U.S. Bancorp (USB) prepares to report its fourth-quarter and full-year 2023 results on Jan 17, analysts have been busy updating their forecasts and ratings. With the company's quarterly revenues expected to improve year over year and earnings projected to decline, let's take a look at what some of Wall Street's most accurate analysts have to say about U.S. Bancorp's prospects.



Oppenheimer analyst Chris Kotowski maintained an Outperform rating on U.S. Bancorp and cut the price target from $66 to $62 on Jan. 3, 2025. This analyst has an accuracy rate of 86%. DA Davidson analyst Peter Winter upgraded the stock from Neutral to Buy and raised the price target from $58 to $60 on Jan. 2, 2025. This analyst has an accuracy rate of 70%. Raymond James analyst Michael Rose upgraded the stock from Market Perform to Outperform with a price target of $57 on Dec. 19, 2024. This analyst has an accuracy rate of 68%. Compass Point analyst David Rochester maintained a Buy rating and increased the price target from $49 to $60 on Dec. 10, 2024. This analyst has an accuracy rate of 65%. Piper Sandler analyst Scott Siefers maintained a Neutral rating and raised the price target from $52 to $58 on Dec. 3, 2024. This analyst has an accuracy rate of 70%.



These analysts' recent actions and ratings reflect a mix of confidence and caution in U.S. Bancorp's performance. While some analysts have increased their price targets and upgraded their ratings, others have maintained more conservative positions. This diversity of opinions highlights the uncertainty surrounding the company's earnings and revenue growth prospects.

As U.S. Bancorp gears up for its Q4 print, investors will be closely watching the company's earnings and revenue growth, as well as any guidance provided by management. With analysts' recent forecast changes in mind, it will be interesting to see how the company's performance stacks up against expectations and whether the stock price reflects these changes.

In conclusion, U.S. Bancorp's upcoming earnings report is likely to be a key catalyst for the stock, with analysts' recent forecast changes providing valuable insights into their confidence in the company's performance. As always, investors should stay informed and make decisions based on their own research and risk tolerance.